Browse > Article
http://dx.doi.org/10.5385/nm.2021.28.3.139

Macrophage Activation Syndrome Presented in a Case of Neonatal Lupus  

Kang, Chang Min (Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine)
Choi, Jinwha (Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine)
Lee, JungHwa (Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine)
Publication Information
Neonatal Medicine / v.28, no.3, 2021 , pp. 139-142 More about this Journal
Abstract
Macrophage activation syndrome (MAS) is a potentially life-threatening complication in many autoimmune diseases. Early recognition and intervention are essential for a favorable outcome. Neonatal lupus, an acquired autoimmune disease in neonates caused by the transplacental passage of maternal autoantibodies, is rare and usually self-limited. Herein, we report a case of MAS in a patient with neonatal lupus, which improved with intravenous immunoglobulin.
Keywords
Macrophage activation syndrome; Neonatal lupus; Immunoglobulins, intravenous;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hon KL, Leung AK. Neonatal lupus erythematosus. Autoimmune Dis 2012;2012:301274.   DOI
2 Alongi A, Naddei R, De Miglio L, Natoli V, Ravelli A. Macrophage activation syndrome in pediatrics. Pediatr Allergy Immunol 2020;31 Suppl 24:13-5.   DOI
3 Heijstek V, Habib M, van der Palen R, van Doorn R, Muller PH. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature. Pediatr Rheumatol Online J 2021;19:13.   DOI
4 Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011;124:1927-35.   DOI
5 Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ. Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease. J Rheumatol 2017;44:996-1003.   DOI
6 Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388-99.   DOI
7 Shimozawa H, Kono Y, Matano M, Suzuki Y, Koike Y, Yada Y, et al. Cytokine profile in two siblings with neonatal lupus erythematosus. Pediatr Int 2015;57:1211-4.   DOI
8 Park JH, Kim SH, Kim HJ, Lee SJ, Jeong DC, Kim SY. Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease. J Perinatol 2015;35:158-60.   DOI
9 Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol 2018;70:616-24.   DOI
10 Han SB, Lee SY, Jeong DC, Kang JH. Should 2016 criteria for macrophage activation syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis? Ann Rheum Dis 2016;75:e44.   DOI
11 Suzuki Y, Takahashi N, Yada Y, Koike Y, Matano M, Nishimura H, et al. Hemophagocytic lymphohistiocytosis in a newborn infant born to a mother with Sjogren syndrome antibodies. J Perinatol 2013;33:569-71.   DOI
12 Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008;47:1686-9   DOI
13 Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 2016; 68:566-76.   DOI